Disruption of the MDM2–p53 interaction strongly potentiates p53-dependent apoptosis in cisplatin-resistant human testicular carcinoma cells via the Fas/FasL pathway

di Koster, R, Timmer-Bosscha, H, Bischoff, R, Gietema, J A, de Jong, S
Pubblicazione 2011

In vitro hypoxia-conditioned colon cancer cell lines derived from HCT116 and HT29 exhibit altered apoptosis susceptibility and a more angiogenic profile in vivo

di Yao, K, Gietema, J A, Shida, S, Selvakumaran, M, Fonrose, X, Haas, N B, Testa, J, O'Dwyer, P J
Pubblicazione 2005

Predictors of adherence to exercise interventions during and after cancer treatment: A systematic review

di Ormel, H.L., van der Schoot, G.G.F., Sluiter, W.J., Jalving, M., Gietema, J.A., Walenkamp, A.M.E.
Pubblicato in Psychooncology (2018)

A phase I study of 1,2-diamminomethyl-cyclobutane-platinum (II)-lactate (D-19466; lobaplatin) administered daily for 5 days.

di Gietema, J. A., de Vries, E. G., Sleijfer, D. T., Willemse, P. H., Guchelaar, H. J., Uges, D. R., Aulenbacher, P., Voegeli, R., Mulder, N. H.
Pubblicazione 1993

A phase I study with MAG-camptothecin intravenously administered weekly for 3 weeks in a 4-week cycle in adult patients with solid tumours

di Wachters, F M, Groen, H J M, Maring, J G, Gietema, J A, Porro, M, Dumez, H, de Vries, E G E, van Oosterom, A T
Pubblicazione 2004

A phase II and pharmacokinetic study with oral piritrexim for metastatic breast cancer.

di de Vries, E. G., Gietema, J. A., Workman, P., Scott, J. E., Crawshaw, A., Dobbs, H. J., Dennis, I., Mulder, N. H., Sleijfer, D. T., Willemse, P. H.
Pubblicazione 1993

Evaluation of sub-acute changes in cardiac function after cisplatin-based combination chemotherapy for testicular cancer

di Altena, R, de Haas, E C, Nuver, J, Brouwer, C A J, van den Berg, M P, Smit, A J, Postma, A, Sleijfer, D Th, Gietema, J A
Pubblicazione 2009

Phase II and pharmacokinetic study of lobaplatin in patients with relapsed ovarian cancer.

di Gietema, J. A., Veldhuis, G. J., Guchelaar, H. J., Willemse, P. H., Uges, D. R., Cats, A., Boonstra, H., van der Graaf, W. T., Sleijfer, D. T., de Vries, E. G.
Pubblicazione 1995

Evaluation of long term cardiotoxicity after epirubicin containing adjuvant chemotherapy and locoregional radiotherapy for breast cancer using various detection techniques

di Meinardi, M T, van der Graaf, W T A, Gietema, J A, van den Berg, M P, Sleijfer, D T, de Vries, E G E, Haaksma, J, Boomsma, F, van Veldhuisen, D J
Pubblicazione 2002

A phase I dose escalation study of BIBW 2992, an irreversible dual inhibitor of epidermal growth factor receptor 1 (EGFR) and 2 (HER2) tyrosine kinase in a 2-week on, 2-week off sc...

di Eskens, F A L M, Mom, C H, Planting, A S T, Gietema, J A, Amelsberg, A, Huisman, H, van Doorn, L, Burger, H, Stopfer, P, Verweij, J, de Vries, E G E
Pubblicazione 2008

601TiP First-in-human phase I study of a novel oral Wee1 inhibitor (Debio 0123) in combination with carboplatin in patients with advanced solid tumours

di Gelderblom, H., Gietema, J.A., Desar, I.M.E., Ajmone, N.M., Jalving, M., Kroep, J.R., Nicolas, V., Vaslin, A., Tobal, K., Purcea, D., van Haren, S.F., Damstrup, L.
Pubblicato in Ann Oncol (2020)

Risk and prognostic significance of metachronous contralateral testicular germ cell tumours

di Schaapveld, M, van den Belt-Dusebout, A W, Gietema, J A, de Wit, R, Horenblas, S, Witjes, J A, Hoekstra, H J, Kiemeney, L A L M, Louwman, W J, Ouwens, G M, Aleman, B M P, van Leeuwen, F E
Pubblicazione 2012

Long-term exposure to circulating platinum is associated with late effects of treatment in testicular cancer survivors

di Boer, H., Proost, J. H., Nuver, J., Bunskoek, S., Gietema, J. Q., Geubels, B. M., Altena, R., Zwart, N., Oosting, S. F., Vonk, J. M., Lefrandt, J. D., Uges, D. R. A., Meijer, C., de Vries, E. G. E., Gietema, J. A.
Pubblicato in Ann Oncol (2015)

Tumour biomarkers: association with heart failure outcomes

di Shi, C., van der Wal, H. H., Silljé, H. H. W., Dokter, M. M., van den Berg, F., Huizinga, L., Vriesema, M., Post, J., Anker, S. D., Cleland, J. G., Ng, L. L., Samani, N. J., Dickstein, K., Zannad, F., Lang, C. C., van Haelst, P. L., Gietema, J. A., Metra, M., Ameri, P., Canepa, M., van Veldhuisen, D. J., Voors, A. A., de Boer, R. A.
Pubblicato in J Intern Med (2020)

Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer

di Beyer, J., Albers, P., Altena, R., Aparicio, J., Bokemeyer, C., Busch, J., Cathomas, R., Cavallin-Stahl, E., Clarke, N. W., Claßen, J., Cohn-Cedermark, G., Dahl, A. A., Daugaard, G., De Giorgi, U., De Santis, M., De Wit, M., De Wit, R., Dieckmann, K. P., Fenner, M., Fizazi, K., Flechon, A., Fossa, S. D., Germá Lluch, J. R., Gietema, J. A., Gillessen, S., Giwercman, A., Hartmann, J. T., Heidenreich, A., Hentrich, M., Honecker, F., Horwich, A., Huddart, R. A., Kliesch, S., Kollmannsberger, C., Krege, S., Laguna, M. P., Looijenga, L. H. J., Lorch, A., Lotz, J. P., Mayer, F., Necchi, A., Nicolai, N., Nuver, J., Oechsle, K., Oldenburg, J., Oosterhuis, J. W., Powles, T., Rajpert-De Meyts, E., Rick, O., Rosti, G., Salvioni, R., Schrader, M., Schweyer, S., Sedlmayer, F., Sohaib, A., Souchon, R., Tandstad, T., Winter, C., Wittekind, C.
Pubblicazione 2013